The people receiving medical care deserve an active voice in determining which research inquiries are ultimately investigated. True participation requires engaging patients right from the start. They need to be present during the crucial phases when initial goals are established and studies are first being designed, while also being provided with complete transparency regarding how choices are finalized. At its core, the realm of scientific discovery is something that should be shared by a much wider audience.
The world of decentralized science is making its way to Mumbai 🇮🇳
On November 5, the Bio community is hosting an engaging afternoon event on the exact same grounds as @EFDevcon. We are uniting builders, researchers, and founders to explore the exciting possibilities of DeSci and AI. A major highlight of our gathering will be the inaugural live demonstration featuring our laboratory robot, Robios.
Please register below to secure your attendance and connect with everyone IRL ↓
Tracing the origins of any research tool is a crucial step to take before incorporating it into your work. Fortunately, Bio’s OpenLabs Index simplifies this evaluation process. The platform serves as a unified directory that houses models, datasets, and scientific software all in one place. Furthermore, it equips you with essential activity and licence signals to ensure your background checks are as seamless as possible.
Every early research concept needs a nurturing environment to grow long before it becomes a formalized publication. To provide this, OpenLabs (@openlabsbio) offers a dedicated hub where investigators can propose a hypothesis and track their ongoing discoveries during the research process. You are welcome to browse the current projects of fellow community members or introduce a unique inquiry of your own.
We want to inform everyone who took part in the NeuroLab Ignition Sale that all utilized BioXP has been successfully returned. This complete reimbursement applies to every single user, covering even the individuals who acquired instant BioXP.
You do not have to take any steps to claim your funds since the entire return procedure was handled automatically. To view your personal records, simply navigate to the transaction history section on the BioXP portal located at https://app.bio.xyz/bioxp
A detailed breakdown showing all BioXP pledges and the specific allocations they generated will be published on the sale page very soon.
Our partnership with the NeuroLab team continues as we work closely together to back the project's ongoing commercial development and long-term research efforts. Please keep an eye out for more news in the future.
Obtaining an unfavorable outcome early on is incredibly valuable because it can spare you months of wasted effort. The fundamental purpose of an initial experiment is to provide clarity on your next steps, helping you choose whether to move forward, pivot to a different approach, or halt the project completely. However, securing financial support for these preliminary tests is difficult when you do not yet have a success story to present. This is exactly where Bio steps in, empowering research teams to gather community funding to reach their subsequent milestone.
Conducting your research is demanding enough, so locating the appropriate open source scientific software should never be a struggle.
To simplify this process, the Open Science Index organizes available resources based on their specific scientific uses. This approach empowers you to begin directly with your unique research question and evaluate the various alternatives side by side.
By reviewing the source registries on a daily basis, we ensure you can always discover the latest releases and verify which projects continue to receive active maintenance. ↓
The latest Ignition Sale has officially launched on Bio.
Currently, @NootropicsDAO_ is developing NeuroLab AI, a system designed to forecast the ways various compounds might impact the brain. This is achieved by linking molecular activity to possible cognitive outcomes.
The primary objective of this project is to guide researchers in deciding which substances they should evaluate next.
Make sure to claim your NDT allocation on Bio by visiting http://app.bio.xyz/agents/neurolab-ai
Our live session kicks off in exactly 2 hours. We invite you to join an insightful conversation featuring the @NootropicsDAO_ team as we take a closer look at NeuroLab AI. Together, we will examine how this technology has the potential to support scientists in evaluating the possible impacts that specific compounds might have on the brain. The dialogue will also provide a comprehensive overview of their ongoing scientific studies, the tools they are currently developing, and their roadmap moving forward. Please be sure to activate your reminder right below.
Every major scientific discovery relies on someone providing the financial backing for that crucial initial experiment. That is why OpenLabs Vault is arriving soon. This upcoming platform offers an innovative approach that allows you to champion early stage research by simply utilizing the interest generated from your USDC. Continue reading to explore exactly how the process functions.
Take a closer look at the inner workings of just one individual human neuron. Inside this solitary cell operates a vast and intricate system, functioning much like a complete universe dedicated to sustaining its life and maintaining its vital links. It is highly fascinating to realize that this complex entity is merely a single piece of a much larger puzzle, given that the human brain is estimated to house approximately 86 billion of these remarkable structures.
The team at @NootropicsDAO_ is currently developing NeuroLab AI, a platform designed to investigate the impacts various compounds might have on the brain. By evaluating everything from cognitive effects to possible adverse reactions, this technology will help researchers determine exactly what should be tested in the laboratory. You will have the opportunity to get involved with this initiative when the upcoming Ignition Sale officially launches on Bio next week. To participate in the event, simply use a combination of BioXP and USDC on @base.
The financial investment required to study a condition impacting eight million individuals is virtually identical to the cost of researching an illness that affects merely eight thousand people. The structural design of the trials, the decade it takes to complete them, and the regulatory agencies involved remain exactly the same.
Ultimately, the only factor that shifts is the final audience purchasing the resulting answer.
Because a demographic of eight thousand individuals does not constitute a viable commercial market, people rarely search for those specific solutions. However, while this smaller group may not be a profitable market, they still have the potential to operate collectively as a fund.
Although your laboratory shuts down for Saturday, your internal systems remain fully active. Throughout the course of today, your body will regenerate approximately 330 billion cells without requiring a single moment of oversight. The formal pursuit of scientific research might take a pause for the weekend, but the continuous processes of biology never take a break.
Within the field of drug discovery, there is a highly unusual statistic that defies standard expectations. Going all the way back to the 1950s, the financial investment required to launch a new drug, when adjusted for inflation, has multiplied by two approximately every nine years. Industry experts have dubbed this phenomenon Eroom's Law because it essentially acts as Moore's Law operating backwards. At this point, no one doubts the actual existence of this trend, leaving the true mystery as to what exactly is driving it.
With exactly 11 days remaining to get involved, the @peptai_ Ignition sale has already achieved an incredible milestone. The event is currently 12.2X oversubscribed, having secured over 610K USDC from a growing community of more than 650 participants.
The opportunity to join will officially conclude on Thursday, May 14 at 1pm UTC. You can participate in the sale by visiting the following link: https://t.co/fiLGxxeQSu
We also invite you to tune into our livestream this TUESDAY for the official unveiling of PeptAI. Please be sure to RSVP below to secure your attendance.
As an important reminder regarding the process, please note that any USDC committed to an Ignition sale is completely locked for the duration of the event. Your funds cannot be withdrawn while the sale remains active. Once the event has officially closed, refunds will then be processed and distributed exclusively to eligible participants.
The timeframe required for protein design is about to shrink from years down to merely months, and surprisingly, the driving force behind this acceleration is not an upgraded model. In the past, scientific software consisted of highly specialized programs that were completely isolated from one another. Even though artificial intelligence successfully enhanced the performance of these individual applications, the connections linking them together still required manual human effort.
The true catalyst for compressing this development schedule is the introduction of autonomous agents that seamlessly navigate the entire software ecosystem. These agents select the precise application required for every phase and verify the results against standardized benchmarks before they advance. Properly assessing these outcomes is a highly demanding task, as agents must understand historical discoveries, recognize genuine innovation, and pinpoint which theories actually merit practical testing.
Providing this complex context is exactly what BIOS accomplishes. It manages comprehensive literature synthesis, novelty analysis, and hypothesis generation, ensuring these essential capabilities are readily accessible to any agent operating within the framework.
The approach that genuinely drastically shortens the timeline features these agents operating around the clock. They only present candidates that achieve excellent computational scores and possess the vital characteristics necessary to succeed in physical laboratory assays. Following this evaluation, the agents interact directly with automated facilities and CROs to formally commission the required experiments. Throughout this entire process, the workflow remains completely uninterrupted, permanently eliminating the need for anyone to manually transfer data from one application to the next.
Lilith operates as an artificial intelligence research agent dedicated to exploring the health patterns that neurodivergent women observe, which are routinely overlooked by medical professionals. To deliver analysis supported by solid research, the system utilizes BIOS as its foundational knowledge layer. Every hypothesis generated during this process is shared openly with the public via the @sciencebeach__ account. You are welcome to experience BIOS firsthand to assist with your personal research endeavors:
Log in to explore more content
Join global crypto users on Binance Square
⚡️ Get latest and useful information about crypto.